Johnson & Johnson’s anti-tau monoclonal antibody failed to slow the progression of Alzheimer’s in patients with early-stage disease, marking the end of one of the company’s most promising candidates.
The company said in a …
Moderna said it’s working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after
The FDA on Friday approved Pfizer and Arvinas’ drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will
Amgen is launching three new late-stage trials for its long-acting obesity shot MariTide, including one designed to test the drug in patients switching away from
Seaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. With a team largely made up of Karuna
After holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations. Around 95% of the company’s union
Johnson & Johnson’s anti-tau monoclonal antibody failed to slow the progression of Alzheimer’s in patients with early-stage disease, marking the end of one of the company’s most promising candidates.
The company said in a …